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The FOXP2 gene, located on human 7q31 (at the SPCH1 locus), encodes a transcription factor containing a
polyglutamine tract and a forkhead domain. FOXP2 is mutated in a severe monogenic form of speech and language
impairment, segregating within a single large pedigree, and is also disrupted by a translocation in an isolated case.
Several studies of autistic disorder have demonstrated linkage to a similar region of 7q (the AUTS1 locus), leading
to the proposal that a single genetic factor on 7q31 contributes to both autism and language disorders. In the
present study, we directly evaluate the impact of the FOXP2 gene with regard to both complex language impairments
and autism, through use of association and mutation screening analyses. We conclude that coding-region variants
in FOXP2 do not underlie the AUTS1 linkage and that the gene is unlikely to play a role in autism or more common
forms of language impairment.
Autism is a neurodevelopmental disorder characterized
by deficits in reciprocal social interaction and commu-
nication, accompanied by repetitive and stereotyped be-
haviors and interests (World Health Organization 1993;
American Psychiatric Association 1994).
Specific language impairment (SLI) is defined as a sig-
nificant deficit in language development that exists de-
spite adequate educational opportunity and normal non-
verbal intelligence. A diagnosis of SLI is made after
ruling out the presence of other conditions, such as au-
tism (Tomblin et al. 1996).
Although autism and SLI are generally accepted to be
clinically distinct, the boundaries between the two con-
ditions are not always clear, and there remains a group
of children who show social and/or language difficulties
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yet fail to meet strict diagnostic criteria for either dis-
order. Some have argued for the formation of a “se-
mantic-pragmatic” classification for these “borderline
autistic/language impaired” individuals (Rapin and Al-
len 1983; Bishop and Rosenbloom 1987).
Language deficits form a major component of the au-
tism diagnostic criteria, and, in general, autistic individ-
uals tend to experience more-severe linguistic impair-
ments than are associated with SLI alone (Lord et al.
1994). Autistic children typically make few spontaneous
remarks, produce stereotyped utterances, and make only
minimal use of gesture (Tager-Flusberg et al. 2001). Al-
though some autistic children may develop acceptable
skills in terms of vocabulary, grammar, and phonology,
they invariably retain fundamental difficulties with the
use of language in a social context (i.e., pragmatics)
(Mawhood et al. 2000). A substantial proportion of au-
tistic children completely fail to develop language at all
(Rapin 1997; Tager-Flusberg et al. 2001). In contrast,
the types of language problems seen in SLI tend to be
more heterogeneous. Children affected by SLI show a
wide range and severity of deficits with respect to the
articulation of speech sounds, verbal expression, and
comprehension of speech (Bishop 1994; Conti-Ramsden
et al. 1997). Pragmatic impairments are usually absent
or mild.
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Figure 1 Autism and language studies of chromosome 7q. The chromosome 7 ideogram shows the order and map distance of markers
used in various studies. Blackened boxes show approximate positions of regions highlighted by linkage studies. Unblackened boxes represent
approximate positions of breakpoints in cytogenetic studies. Each MLS shown was obtained in the region highlighted for the appropriate linkage
study. The methods of LOD estimation varied between studies. Note that the SPCH1 linkage has been directly attributed to the FOXP2 gene.
There is now a large amount of evidence, from family
and twin studies, indicating a strong role for genetic
factors in both autism (Folstein and Rutter 1977; Stef-
fenburg et al. 1989; Bolton et al. 1994; Bailey et al. 1995)
and SLI (Lewis and Thompson 1992; Bishop et al. 1995;
Tomblin and Buckwalter 1998). However, it is accepted
that each of these conditions is complex in nature, with
several loci interacting to produce a genetic liability to
disease onset (Pickles et al. 1995).
Recent advances in technology and statistical genetics
have allowed the completion of several genomewide
scans using sibling pairs affected by autism. The first of
these studies yielded a maximum LOD score (MLS) of
3.55 in a 40-cM region on the long arm of human chro-
mosome 7, between markers D7S530 and D7S684, in a
subset of families from the United Kingdom (the AUTS1
locus [MIM 209850]; fig. 1) (International Molecular
Genetic Study of Autism Consortium [IMGSAC] 1998).
The involvement of this AUTS1 locus in autism is further
supported by several independent linkage investigations
with differing degrees of significance and varying chro-
mosomal locations. (fig. 1) (Ashley-Koch et al. 1999;
Collaborative Linkage Study of Autism 1999; Phillippe
et al. 1999; Risch et al. 1999; IMGSAC 2001a).
Concurrent studies of the KE family, a unique three-
generation pedigree with a severe monogenic speech and
language disorder, independently yielded strong evidence
for linkage to a similar region of 7q31, between markers
D7S2459 and D7S643 (the SPCH1 locus [MIM 602081];
fig. 1) (Fisher et al. 1998; Lai et al. 2000). The KE phe-
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Figure 2 Schematic of FOXP2 (adapted with permission from Lai et al. [2001]). Numbers in black indicate exon numbers. Numbers in
grey indicate intron numbers as used in table 3. All exons are shown to scale. Introns are shown to scale with each other, and the sizes of all
introns 15 kb are given in brackets (in kb). Positions of all microsatellites and SNPs used for association analysis are indicated by arrows, and
distances (in kb) are given from the nearest coding exon. Exons 5 and 6 contain a polyglutamine encoding tract; exons 12–14 contain the
forkhead (fox) domain; exons 3a and 3b are alternatively spliced; the KE mutation is found in exon 14; the CS translocation breakpoint is
between exon 3b and exon 4.
notype is characterized by severe orofacial dyspraxia,
which impedes complex articulatory movement, accom-
panied by extreme impairments in both expressive and
receptive language skills. There is also evidence of non-
verbal deficits in some individuals (Vargha-Khadem et al.
1995). Although the affected members of the KE family
show no autistic features and do not meet strict diagnostic
criteria for SLI, the overlap between the SPCH1 and
AUTS1 loci raised the question of whether a single gene
on 7q might be involved in both autism and SLI (Folstein
and Mankoski 2000). Such a hypothesis is strengthened
by cytogenetic studies of individuals with chromosome 7
abnormalities (fig. 1). Ashley-Koch et al. (1999) described
a family with a pericentric inversion of the long arm of
chromosome 7 (inv[7][q22-q31.2]), transmitted from an
unaffected mother to all three of her children. Interest-
ingly, two of the three siblings in this family were affected
by autism, and the third presented with a severe expres-
sive-language disorder. Vincent et al. (2000) characterized
a translocation transmitted from an unaffected mother to
an autistic child (t[7;13][q31.2;q21]) and mapped the
breakpoint within a highly conserved, brain-expressed
gene of unknown function (RAY1) between markers
D7S2460 and D7S633.Warburton et al. (2000) described
two unrelated individuals, one with autism and a second
with a severe expressive-language impairment, both of
whom showed de novo abnormalities involving break-
points on chromosome 7q31 (inv[7][p12.2;q31.3] and
t[2;7][p23;q31.3], respectively). Finally, Lai et al. (2001)
described a child (referred to as “CS”) affected by a severe
orofacial dyspraxia and language deficits similar to those
seen in the KE family, with a de novo translocation
(t[5;7][q22;q31.2]) mapping to the SPCH1 region.
Recently, the gene mutated in the KE family was iden-
tified as FOXP2 (MIM 605317) (Lai et al. 2001). The
FOX genes encode a large family of transcription fac-
tors, all of which possess a winged-helix—or forkhead
box (“fox”)—DNA-binding domain. The known se-
quence of FOXP2, as reported by Lai et al. (2001), is
organized into 19 exons (2 of which are alternatively
spliced), and the major splice form encodes a 715-residue
protein containing a characteristic fox domain (exons
12–14) and a 40-residue polyglutamine tract (exons 5
and 6). The polyglutamine repeat is encoded by a mix-
ture of CAG and CAA codons and has been demon-
strated to be stable in normal individuals (Lai et al.
2001). Themutation identified in the KE family is a GrA
transition in exon 14 that cosegregates with the speech
and language disorder in the KE pedigree. This nonsyn-
onymous change results in an arginine-to-histidine sub-
stitution at a highly conserved residue within the fox
domain (Lai et al. 2001). Furthermore, the FOXP2 gene
was directly disrupted by the chromosomal breakpoint
of the unrelated translocation patient, CS. Lai et al.
(2001) suggested that the KE and CS phenotypes may
be caused by haploinsufficiency of FOXP2 at a key stage
of embryogenesis, which results in the abnormal devel-
opment of neural structures important for speech and
language.
Clearly, there is strong support for the role of chro-
mosome 7q31 in the etiology of both autism and lan-
guage disorders. However, questions remain with regard
to the relevance of FOXP2 within more common and
genetically complex forms of language impairment, and
it is still a matter of debate as to whether the phenotypic
and genetic overlaps between autism and SLI are caused
by the same or by different loci. The present study there-
fore presents the characterization of FOXP2within sam-
ples of patients with SLI and autism, with two aims. The
first is to assess the relevance of the FOXP2 gene within
forms of language impairment more common than those
found in the KE family and in the translocation patient
CS, and the second is to directly evaluate the hypothesis
that the overlap in SPCH1 and AUTS1 mapping da-
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Table 1
Association of FOXP2 with Intronic Microsatellites: TDT within Autistic Families
MICOSATELLITEa
AND ALLELE
(ALLELE SIZE
IN BP)
FREQUENCYb
(%)
NO. OF ALLELES
Paternal Maternal Combined
Transmitted
Not
Transmitted 2x Transmitted
Not
Transmitted 2x Transmitted
Not
Transmitted 2x
Intron 2: (TAGA)n:
3 (458) 50.7 41 52 1.30 56 47 .79 113 115 .02
2 (454) 25.9 48 36 1.71 38 42 .20 101 93 .33
4 (462) 16.5 30 25 .45 37 38 .01 70 66 .12
Other 6.8 14 20 10 14 24 34
Intron 2: (CA)n:
7 (195) 39.3 48 60 1.33 56 75 2.76 109 140 3.86
2 (185) 23.7 44 30 2.65 50 54 .15 96 86 .55
3 (187) 22.8 35 41 .47 48 37 1.42 86 81 .15
Other 14.2 37 33 41 29 78 62
Intron 3b: (CA)n:
7 (435) 30.2 46 44 .04 42 48 .4 93 97 .08
8 (437) 21.1 31 28 .15 36 36 .00 70 67 .07
9 (439) 14.9 20 34 3.63 26 21 .53 49 58 .76
6 (433) 13.4 28 19 1.72 23 19 .38 51 38 1.90
Other 20.7 37 37 36 39 74 77
Intron 16: (CA)n:
2 (225) 45.5 71 51 3.28 42 54 1.50 116 108 .29
8 (239) 27.2 38 37 .01 34 24 1.72 75 64 .87
7 (237)c 10.9 10 31 10.76 12 18 1.20 22 49 10.27
Other 16.2 36 36 35 27 73 65
NOTE.—Empirical P values for transmission of all alleles was 1.1 for alleles of all microsatellites, with the exception of intron 3b ([CA]n),
for which .Pp .08
a For positions of microsatellites, see figure 2.
b Alleles with a frequency !10% are grouped as “other.”
c Allele-specific TDT for allele 7 combined (underlined): (uncorrected).Pp .01
Table 2
Association of FOXP2 with Intronic
Microsatellites: QTDT within Language-
Impaired Families
MICROSATELLITE
2x
ELS RLS NWR
Intron 2: (TAGA)n 2.38 .95 7.88
Intron 2: (CA)n 7.14 9.60 8.89
Intron 3b: (CA)n 8.23 10.18 7.69
Intron 16: (CA)n 2.58 1.30 3.11
NOTE.—All P values were 1.1.
ta reflects the involvement of a single gene—that is,
FOXP2.
For the present study, 169 multiplex families with au-
tism (857 individuals) were selected. These individuals
represent the complete IMGSAC cohort (IMGSAC
2001b) and thus include those used in the original iden-
tification of AUTS1 (IMGSAC 1998). Families were col-
lected over four successive stages, and affection status
was assessed using a variety of standardized tests. In
brief, parents from families identified through an initial
screen were administered the Autism Diagnostic Inter-
view–Revised (ADI-R [Lord et al. 1994]) and the Vine-
land Adaptive Behaviour Scales (Sparrow et al. 1984).
Potential cases were assessed using the Autism Diag-
nostic Observation Schedule (ADOS [Lord et al. 1994])
or the ADOS-Generic (ADOS-G [Lord et al. 2000]).
Where possible, psychometric evaluation was conducted
using Raven’s progressive matrices (Raven 1989) or the
Mullen Scales of Early Learning (Mullen 1995), as well
as the British Peabody Picture Vocabulary Test III (Dunn
and Dunn 1997) or an appropriate translation. A phys-
ical examination was undertaken and allowed the ex-
clusion of children with signs of tuberous sclerosis.
Where possible, affected individuals were karyotyped,
and those found to have any chromosome abnormalities,
including fragile X, were excluded.
In addition, we selected 43 families with language im-
pairment (210 individuals) who form a subset of the SLI
Consortium (SLIC) genome-screen sample (SLIC 2002).
Probands were recruited by the Newcomen Centre at
Guy’s Hospital, London, through three special schools
for language disorders and through Afasic, a support
organization for people with developmental and lan-
guage impairments. All probands, either currently or in
the past, had language skills 11.5 SD below the nor-
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Table 3
Polymorphisms Detected in FOXP2
INTRON/EXONa
AND POSITIONb CHANGE
FREQUENCY IN
INDIVIDUALS WITHc
Autism
( )np 48
SLI
( )np 43
Intron 3:
102 bp from exon 3a T/A 9 11
Intron 3a:
32 bp from exon 3b A/G 0 1
48 bp exon3bd T/C 15 19
68 bp from exon3b G/A 1 0
Intron 5:
17 bp from exon5 T/G 8 10
Intron 5/Exon 6:
… Ins CAGCAG 0 1
Intron 11:
9 bp from exon11 T/C 1 1
80 bp from exon12 A/G 0 1
Intron 13:
30 bp from exon13 C/G 1 2
Intron 14:
24 bp from exon14 T/C 0 1
44 bp from exon15 T/G 2 0
58 bp from exon15 T/C 3 0
a For intron numbers, see figure 2.
b Position is given in relation to nearest exon; “” denotes that
the SNP is found 5′ to the exonic sequence, and “” denotes that
the SNP is found 3′ to the exonic sequence.
c Frequency of heterozygotes within the sample tested.
d Polymorphism used to type individuals for association analysis.
mative mean for their chronological age, on the receptive
and/or expressive scales of the Clinical Evaluation of
Language Fundamentals (CELF-R) battery (Semel et al.
1992). Any proband or sibling found to have a non-
verbal IQ of !80 was excluded from the sample. Ad-
ditional exclusion criteria included an International
Classification of Diseases–10th Revision/Diagnostic and
Statistical Manual of Mental Disorders–4th Edition di-
agnosis of childhood autism.
The SLIC study used this sample in an investigation
of three quantitative measures of language abilities, none
of which showed linkage to chromosome 7q (SLIC
2002). A comprehensive description of the relevant co-
horts can be found in reports by IMGSAC (2001b) and
SLIC (2002).
To begin, we used RepeatMasker software (BCM
Search Launcher Web site) to identify four novel intronic
polymorphic microsatellites (fig. 2) that lie within BACs
(NH0095P09, RG250D13, and NH563O05) covering
the FOXP2 sequence. Fluorescently labeled primers
were designed (sequences are available from the authors
on request) and were used to amplify all four microsa-
tellites in available members of the families described
above. The products were genotyped on ABI377 se-
quencing machines (PE Applied Biosystems), as de-
scribed elsewhere (SLIC 2002), and were tested for as-
sociation, as follows.
Children from the autistic families were classified as
“affected” or “unknown” and were tested for associa-
tion through use of a transmission/disequilibrium test
(TDT) within the sib_tdt program from the ASPEX
package version 2.2 (The ASPEX Linkage Analysis Pack-
age ftp site). This program calculates probabilities for
x2 statistics by permuting parental alleles while fixing
the identity-by-descent status of siblings within a family,
thereby allowing the use of multiple siblings within a
nuclear family.
We found no evidence for association within the autism
group at the marker level ( ; table 1). AlthoughP 1 .05
allele-specific TDT indicated a weak association (Pp
) between the 237-bp allele of the intron 16 micro-.01
satellite and autistic disorder, the excess of nontransmitted
alleles in this case (22 transmitted and 49 nontransmitted;
see table 1) corresponds to a protective effect. Further-
more, after appropriate correction for multiple testing,
this association was rendered nonsignificant.
The heterogeneity of the SLI phenotype rendered the
derivation of a consistent affection status impractical.
We therefore employed three quantitative measurements
of language abilities to examine FOXP2 association
within the SLI cohort. The CELF-R was used to derive
scores of expressive and receptive language abilities (ELS
and RLS, respectively) (Semel et al. 1992). Each score
is calculated from performance on three subtests des-
ignated to be primarily receptive or expressive in nature.
The exact combination of individual tests used is de-
pendent upon subject age. Additive raw scores from each
segment are transformed to derive standardized scores
with a mean of 100 and an SD of 15 in the general
population calibration sample (Semel et al. 1992).
In addition, a test of nonword repetition (NWR) was
used to assess phonological short-term memory (Gath-
ercole et al. 1994). In this test, subjects are required to
repeat tape-recorded nonsensical words of increasing
length and complexity (e.g., “brufid” and “contram-
ponist”). Studies show that individuals with current lan-
guage impairments, as well as those who had language
difficulties in early childhood which later resolved, per-
form poorly on this test (Gathercole et al. 1994; Bishop
et al. 1999). In addition, it has been suggested that per-
formance on the nonword repetition task is the best
index of disorder in the KE pedigree (Vargha-Khadem
et al. 1998).
Association was evaluated by the QTDT (quantitative
transmission/disequilibrium test) program (Abecasis et
al. 2000; QTDTHome Page), which employs a variance-
components model that partitions association into be-
tween- and within-family components. The QTDT pro-
gram includes a permutation framework, which allows
the derivation of empirical P values for the sample being
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Figure 3 FOXP2 exon 6. A, Family 43 pedigree. Both the mother and father have no reported history of language problems. Child 1 is
clinically normal, child 2 is clinically affected, and child 3 has a reported language delay but is too young to test formally. B, The CAGCAG
insertion in FOXP2 exon 6. The boxed area represents the possible site for CAGCAG insertion. Underlined bases represent primers for exon
5. Exonic sequence is represented by capital letters; intronic sequence is represented by lowercase letters.
Table 4
SNP Association Analyses of FOXP2: TDT within Autistic Families
SNPa
FREQUENCY
(%)
NO. OF ALLELES
Paternal Maternal Combined
Transmitted
Not
Transmitted 2x Transmitted
Not
Transmitted 2x Transmitted
Not
Transmitted 2x
Intron 3a 55.6 54 45 .82 58 57 .01 137 127 .38
5′ (923875) 48.5 31 39 .91 35 23 2.48 91 87 .09
NOTE.—All P values were 1.1
a For SNP positions, see figure 2.
evaluated. This corrects for small sample sizes or devi-
ations of quantitative traits from multivariate normality.
We performed 1,000 simulations for each of the above
traits and again found no evidence for association
( ) (table 2).P 1 .05
Despite the lack of positive findings from the associ-
ation analyses, it remained possible that some individ-
uals may harbor FOXP2 mutations that were indiscern-
ible at the whole-sample level. We therefore initiated a
mutation screen of the FOXP2 coding sequence by
means of denaturing high performance liquid chroma-
tography (DHPLC) (Kuklin et al. 1997).
DHPLC analysis was performed for all 43 probands
of the families with SLI described above. For the autism
cohort, a subset of 48 affected individuals were selected
who contributed to the linkage peak on 7q. This en-
riched for individuals who are likely to carry etiological
variants at the AUTS1 locus.
Primers, taken from the Lai et al. (2001) study and
available on request, were used to amplify all 19 FOXP2
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Table 5
SNP Association Analyses of FOXP2: QTDT
within Language-Impaired Families
SNPa
Frequency
(%)
2x
ELS RLS NWR
Intron 3a 51.0 .07 .81 .65
5′ (923875) 40.6 .28 2.03 .03
NOTE.—All P values were 1.1
a For SNP positions, see figure 2.
exons and surrounding intron-exon boundaries, by
means of a touchdown PCR protocol (PCR Protocol for
WAVE Machine Web site). DHPLC analysis was per-
formed using theWAVEDNA Fragment Analysis System
(Transgenomic), and fragments that showed a variant
elution pattern were directly sequenced.
We identified a total of 11 sequence variants, all of
which were single-base substitutions within intronic
regions (table 3). No changes were seen within exons
12–14, which contain the fox domain.
In one family with SLI (family 43), we identified a
CAGCAG insertion within a polyglutamine stretch at
the intron/exon border of exon 6 (fig. 3). This region
represents the longest stretch of pure CAG repeatswithin
the polyglutamine region and thus is the most likely
place for an expansion to occur. We genotyped all avail-
able members of this family, but the expansion did not
cosegregate with language impairment (fig. 3). In ad-
dition, the insertion may actually fall within intronic
sequence—the exact position of the insertion remains
unclear, because of the repetitive nature of this stretch
of DNA—and it does not alter the reading frame of the
sequence. It therefore appears likely that this expansion
simply represents a rare polymorphism that is not rel-
evant to the SLI phenotype.
The DHPLC analysis identified a common single-nu-
cleotide polymorphism (SNP) within intron 3a of the
FOXP2 gene (fig. 2). This intron 3a polymorphism in-
volves a TrC transition that destroys an AflII site within
the sequence and therefore could be directly typed via
a restriction enzyme assay. One hundred sixty-nine fam-
ilies with autism were again tested through use of the
sib_tdt program from the ASPEX package (v2.2), and
43 families with SLI were tested within the QTDT pro-
gram (Abecasis et al. 2000), as described above. We
found no evidence for association with this SNP, within
either the autism or the SLI groups (tables 4 and 5).
Although the Lai et al. (2001) article presented the
entire coding region of the FOXP2 gene, the transcrip-
tion start site could not be defined, and northern analyses
indicated the existence of additional 5′ and/or 3′ un-
translated exons that remain uncharacterized. Given the
wide expression pattern of FOXP2 (Lai et al. 2001), we
postulated that it was likely to represent a housekeeping
gene and therefore initiated a search for CpG islands in
the genomic sequence immediately upstream of the
FOXP2 gene (CpG Islands Web site). Complementary
bioinformatic analyses (e.g., Nix [MRCHumanGenome
Mapping Project Resource Center Web site] and Pro-
moter Inspector [Genomatix Web site], and Ensembl
[Ensembl Genome Server]) indicated that the closest
CpG island lay 340 kb upstream of the present FOXP2
coding sequence.
Similarity searches demonstrated that this sequence
was highly homologous (83% identity) to a CpG-rich
region upstream of the mouse Foxp2 gene. Furthermore,
this murine sequence was directly linked to the Foxp2
coding region in three independent ESTs (AW490098,
BB660527, and BB656124), indicating that it is tran-
scribed as part of the mouse Foxp2 mRNA.
As a final verification step, we therefore typed an SNP
adjacent to this CpG island (SNP 923875) (dbSNP
Home Page), through use of a restriction enzyme assay.
We found no evidence for association at this 5′ SNP, in
either the autism or the SLI groups (tables 4 and 5).
In the absence of any mutation or association evidence
to suggest otherwise, we must therefore conclude that
FOXP2 is unlikely to play a major role in the onset of
autism or SLI. As a corollary, since the autism cases
studied here included those originally used in the detec-
tion of the AUTS1 locus and the sample was enriched
for individuals who showed linkage to 7q31, we can
conclude that the SPCH1 and AUTS1 loci are attrib-
utable to different genes that, coincidentally, lie in similar
positions on chromosome 7q.
Finally, it would appear that the role of FOXP2 in
speech and language disorders does not generalize to
more common and genetically complex forms of lan-
guage impairment within our SLIC cohort. However, it
is worth noting that although the probands with SLIC
were chosen to represent a diverse range of impairments
spread over many linguistic domains, it remains possible
that FOXP2 variations may be involved in specific and
distinct forms of speech and language impairments not
represented within our sample.
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